|
|
|
The agreement might be a boon for individuals with diabetes. The longstanding rumors of an Apple Watch with blood sugar monitoring just gained some credibility. The Telegraph and Forbes report that UK health tech firm Rockley Photonics lately confirmed in an SEC filing that Apple has been its largest buyer for the past two years, and that it has a continuing deal to develop future merchandise. Rockley's focus has been on sensors that BloodVitals home monitor blood glucose, strain and even alcohol ranges, suggesting that at the least one of those features will likely be available in a future Apple Watch. Apple's support for people with diabetes has to date been restricted to carrying third-celebration displays in its shops. There's no assure the Rockley deal will result in transport merchandise. Apple hasn't been shy about focusing the Apple Watch on health, however, and there's loads of industry curiosity in developing wearable blood sugar sensors that do not require needles. If Apple can build the know-how right into a mainstream product just like the Watch, it might provide a bonus to anyone tired of jabbing themselves to maintain their diabetes in check. Rockley's other technologies could help, too. Blood stress tracking may alert you to issues like stress, and alcohol monitoring may keep your drinking in moderation. Whether or not that's feasible is another matter. Apple still has to consider factors like battery life and value, and it's totally potential that you just could possibly be ready a while for all these features (assuming they ever ship) even when the tech is otherwise prepared. |
|
發表於